C-reactive protein as a biomarker of response to inhaled corticosteroids among patients with COPD

ConclusionWe did not find a reduced risk of moderate and/or severe COPD exacerbations among COPD patients with varying CRP levels currently exposed to ICS. However, low-grade systemic inflammation was associated with all-cause mortality among COPD patients.
Source: Pulmonary Pharmacology and Therapeutics - Category: Respiratory Medicine Source Type: research